STOCK TITAN

Squarepoint entities disclose multi-affiliate stakes in Cartesian Therapeutics (RNAC) — 8.3% each

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Cartesian Therapeutics, Inc. disclosure: multiple Squarepoint entities report beneficial ownership stakes in Common Stock totaling between 30,949 and 2,209,601 shares per entity as filed on 03/09/2026.

The filing lists Squarepoint Ops LLC, Squarepoint Capital LLP, Squarepoint Operations Private Limited, and Squarepoint (DIFC) Ltd each holding 2,209,601 shares (reported 8.34% of the class), Squarepoint Master Fund Limited holding 2,178,652 shares (8.22%), and Squarepoint Core Master Fund Limited holding 30,949 shares (0.12%).

Positive

  • None.

Negative

  • None.

Insights

Squarepoint's institutional positions cross multiple affiliates with shared voting and dispositive power.

The filing attributes shared voting and shared dispositive power to each Squarepoint affiliate: 2,209,601 shares for four affiliates, 2,178,652 for one, and 30,949 for the smaller affiliate, with percentages shown per entity.

These entries indicate coordinated holdings reported by separate legal entities; subsequent filings would clarify any consolidation of beneficial ownership or changes in voting alignment.

Positions represent single‑entity percentages near 8.3%, implying sizable passive stakes by funds.

The reported percentages are 8.34% per four affiliates and 8.22% for the master fund, with one small affiliate at 0.12%. Each entry ties a share count to a clear percentage in the filing.

These holdings may affect float calculations; further filings could reveal aggregated exposure or any Section 13(d) triggers if ownership is consolidated.






03/09/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Squarepoint Ops LLC
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Squarepoint Capital LLP
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Squarepoint Operations Private Limited
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Squarepoint (DIFC) Ltd
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Squarepoint Master Fund Limited
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Squarepoint Core Master Fund Limited
Signature:/s/ John Weitzer
Name/Title:Chief Compliance Officer
Date:03/13/2026
Cartesian

NASDAQ:RNAC

View RNAC Stock Overview

RNAC Rankings

RNAC Latest News

RNAC Latest SEC Filings

RNAC Stock Data

211.15M
10.19M
Biotechnology
Pharmaceutical Preparations
Link
United States
FREDERICK